News
- Author:
- Randy Dotinga
Publish date: October 3, 2022
Leukemia & Lymphoma Society project offers free genomic screening, plus access to subtrials.
News
- Author:
- Randy Dotinga
Publish date: September 30, 2022
Study suggests that the venetoclax-gilteritinib drug combination “potentially improves response frequency and depth.”
News
- Author:
- Randy Dotinga
Publish date: September 19, 2022
Sibling cancer doctors turned their Twitter account into an online watering hole for oncologists.
News
- Author:
- Randy Dotinga
Publish date: September 19, 2022
This rare blood disorder is often misdiagnosed, but a pricey new drug offers relief.
News
- Author:
- Randy Dotinga
Publish date: September 19, 2022
If these tests become standard, the oncology field will need to navigate a thicket of new challenges.
Article
- Author:
- Randy Dotinga
Publish date: September 16, 2022
Article
- Author:
- Randy Dotinga
Publish date: September 13, 2022
Outdated ACC/AHA guidelines haven’t caught up to newer dat...
News
- Author:
- Randy Dotinga
Publish date: August 30, 2022
Prospective Dutch study suggests no harm in de-escalating therapy in cT1-2N1 patients.
News
- Author:
- Randy Dotinga
Publish date: August 29, 2022
Study contends that discrepancies could threaten patient outcomes by obscuring true level of response.
News
- Author:
- Randy Dotinga
Publish date: August 29, 2022
While disorders such as Graves’ disease may double the odds of tumors, the overall risk remains low.
News
- Author:
- Randy Dotinga
Publish date: August 29, 2022
New analysis that refines understanding of two subtypes could lead to better prognoses.
News
- Author:
- Randy Dotinga
Publish date: August 24, 2022
Two new studies spotlight age disparities that continue to plague blood cancer care.
News
- Author:
- Randy Dotinga
Publish date: August 17, 2022
AAD, ILDS want to hear about what you’re seeing in the clinic.
News
- Author:
- Randy Dotinga
Publish date: August 17, 2022
Watch out for lesions that may look like herpes, shingles, syphilis, and other conditions, dermatologists advise.
News
- Author:
- Randy Dotinga
Publish date: August 16, 2022
Results could spur FDA approval as frontline therapy.
